Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on McKesson (MCK – Research Report) and Medtronic (MDT – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
McKesson (MCK)
In a report issued on March 5, Charles Rhyee from TD Cowen maintained a Buy rating on McKesson, with a price target of $1012.00. The company’s shares closed last Friday at $919.26.
According to TipRanks.com, Rhyee is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for McKesson with a $997.10 average price target, which is a 7.5% upside from current levels. In a report issued on February 18, Barclays also maintained a Buy rating on the stock with a $1050.00 price target.
See the top stocks recommended by analysts >>
Medtronic (MDT)
TD Cowen analyst Josh Jennings maintained a Buy rating on Medtronic today and set a price target of $119.00. The company’s shares closed last Friday at $90.90.
According to TipRanks.com, Jennings is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Medtronic with a $113.83 average price target.
